Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nuala Moran

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Nature Biotechnology|April 12, 2011
p38 kinase inhibitor approved for idiopathic pulmonary fibrosisNuala Moran
Nature Biotechnology|June 9, 2012
Agency defies advice and rejects gene therapy for third timeNuala Moran
Nature Biotechnology|March 9, 2013
Wyss Institute to rise in Merck Serono shellNuala Moran
Nature Biotechnology|June 12, 2013
AstraZeneca juggernaut heads for CambridgeNuala Moran
Nature Biotechnology|February 9, 2008
Priced out of the UK marketNuala Moran
Nature Biotechnology|March 10, 2009
Report blames NICE for hastening decline of UK biotechNuala Moran
Nature Biotechnology|October 11, 2008
Roche consolidates grip on anti-angiogenesis marketNuala Moran
Nature Biotechnology|October 11, 2008
London forges 2 billion pounds research clusterNuala Moran
Nature Biotechnology|December 13, 2006
Danish biotech outperforms its European counterpartsNuala Moran
Nature Biotechnology|June 9, 2007
Licensing deals morph to acquisitions in seller's marketNuala Moran
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Nature Biotechnology|April 12, 2011
p38 kinase inhibitor approved for idiopathic pulmonary fibrosisNuala Moran
Nature Biotechnology|June 9, 2012
Agency defies advice and rejects gene therapy for third timeNuala Moran
Nature Biotechnology|March 9, 2013
Wyss Institute to rise in Merck Serono shellNuala Moran
Nature Biotechnology|June 12, 2013
AstraZeneca juggernaut heads for CambridgeNuala Moran
Nature Biotechnology|February 9, 2008
Priced out of the UK marketNuala Moran
Nature Biotechnology|March 10, 2009
Report blames NICE for hastening decline of UK biotechNuala Moran
Nature Biotechnology|October 11, 2008
Roche consolidates grip on anti-angiogenesis marketNuala Moran
Nature Biotechnology|October 11, 2008
London forges 2 billion pounds research clusterNuala Moran
Nature Biotechnology|December 13, 2006
Danish biotech outperforms its European counterpartsNuala Moran
Nature Biotechnology|June 9, 2007
Licensing deals morph to acquisitions in seller's marketNuala Moran
Pageof 5